Abstract
This study aimed to develop a determination method of mycophenolic acid (MPA) in biological samples using salting-out liquid–liquid microextraction from human plasma samples based on the formation of a fluorescent complex with terbium ion and its application in quantification of the MPA in clinical samples. MPA extracted from plasma samples by salting-out liquid–liquid microextraction after protein precipitation by acetonitrile. Then, the fluorescence intensity was measured at 545 nm using an excitation wavelength of 347 nm after optimization of extraction parameters. Under the optimum conditions for the developed method, it provided a linear range between 0.5 and 5.0 µg/mL with a correlation coefficient (R2) of 0.998, and then, the validation was performed according to the FDA guideline and the developed method could quantify MPA concentration in real plasma samples. The results showed that linearity, accuracy, and precision of the developed analysis method were suitable for the determination of the MPA in plasma samples.
Similar content being viewed by others
References
Alshishani A, Salhimi SM, Saad B (2018) Salting-out assisted liquid-liquid extraction coupled with hydrophilic interaction chromatography for the determination of biguanides in biological and environmental samples. J Chromatogr B Anal Technol Biomed Life Sci 1073:51–59. https://doi.org/10.1016/j.jchromb.2017.12.013
Bahrami G, Mohammadi B (2006) An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human pharmacokinetic studies. Clin Chim Acta 370:185–190. https://doi.org/10.1016/j.cca.2006.02.017
Bansal S, DeStefano A (2007) Key elements of bioanalytical method validation for small molecules. AAPS J 2007:9. https://doi.org/10.1208/aapsj0901011
Carlucci F, Anzini M, Rovini M, Cattaneo D, Merlini S, Tabucchi A (2007) Development of a CE method for the determination of mycophenolic acid in human plasma: a comparison with HPLC. Electrophoresis 28:3908–3914. https://doi.org/10.1002/elps.200700190
Dasgupta A (2009) Advances in chromatographic techniques for therapeutic drug monitoring. CRC Press, Boca Raton
Ershadi S, Shayanfar A (2018) Are LOD and LOQ reliable parameters for sensitivity evaluation of spectroscopic methods? J AOAC Int 101:1212–1213. https://doi.org/10.5740/jaoacint.17-0363
Ham JY et al (2016) Usefulness of mycophenolic acid monitoring with PETINIA for prediction of adverse events in kidney transplant recipients. Scand J Clin Lab Invest 76:296–303. https://doi.org/10.3109/00365513.2016.1149879
Hosotsubo H et al (2001) Rapid and simple determination of mycophenolic acid in human plasma by ion-pair RP-LC with fluorescence detection. J Pharm Biomed Anal 24:555–560. https://doi.org/10.1016/S0731-7085(00)00442-8
Kuhn J, Götting C, Kleesiek K (2010) Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Talanta 80:1894–1898. https://doi.org/10.1016/j.talanta.2009.10.040
Lamb KE, Lodhi S, Meier-Kriesche HU (2011) Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 11:450–462. https://doi.org/10.1111/j.1600-6143.2010.03283.x
Mandla R, Line PD, Midtvedt K, Bergan S (2003) Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients. Ther Drug Monit 25:407–414. https://doi.org/10.1097/00007691-200306000-00025
Ozkan SA (2018) Analytical method validation: the importance for pharmaceutical analysis. Pharm Sci 24:1–2. https://doi.org/10.15171/PS.2018.01
Ruiz-Medina A, Llorent-Martinez EJ, Ortega-Barrales P, Cordova MLFD (2011) Lanthanide-sensitized luminescence as a promising tool in clinical analysis. Appl Spectrosc Rev 46:561–580. https://doi.org/10.1080/05704928.2011.600401
Shayanfar A, Ghavimi H, Zolali E, Jouyban A (2015) Determination of mycophenolic acid in plasma samples using the terbium-sensitized luminescence method J. Appl Spectrosc 82:614–619. https://doi.org/10.1007/s10812-015-0153-5
Shehata M et al (2009) Effect of conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium on maximum tolerated dose and gastrointestinal symptoms following kidney transplantation. Transplant Int 22:821–830. https://doi.org/10.1111/j.1432-2277.2009.00877.x
Shen B et al (2009) Determination of total, free and saliva mycophenolic acid with a LC-MS/MS method: application to pharmacokinetic study in healthy volunteers and renal transplant patients. J Pharm Biomed Anal 50:515–521. https://doi.org/10.1016/j.jpba.2009.05.030
Soltani N, Manzoori JL, Amjadi M, Lotfipour F, Jouyban A (2016) Development and validation of a spectrofluorimetric determination of calf thymus DNA using a terbium-danofloxacin probe. Pharm Sci 22:2–8. https://doi.org/10.15171/PS.2016.02
Syed M, Srinivas NR (2016) A comprehensive review of the published assays for the quantitation of the immunosuppressant drug mycophenolic acid and its glucuronidated metabolites in biological fluids. Biomed Chromatogr 30:721–748. https://doi.org/10.1002/bmc.3682
Tang YQ, Weng N (2013) Salting-out assisted liquid-liquid extraction for bioanalysis. Bioanalysis 5:1583–1598. https://doi.org/10.4155/bio.13.117
Upadhyay V, Trivedi V, Shah G, Yadav M, Shrivastav PS (2014) Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry. J Pharm Anal 4:205–216. https://doi.org/10.1016/j.jpha.2013.06.001
Yin J, Wang S, Yang G, Yang G, Chen Y (2006) Molecularly imprinted solid-phase extraction for rapid screening of mycophenolic acid in human plasma. J Chromatogr B Anal Technol BiomedLife Sci 844:142–147. https://doi.org/10.1016/j.jchromb.2006.07.009
Zhang J, Wu H, Kim E, El-Shourbagy TA (2009) Salting-out assisted liquid/liquid extraction with acetonitrile: a new high throughput sample preparation technique for good laboratory practice bioanalysis using liquid chromatography-mass spectrometry. Biomed Chromatogr 23:419–425. https://doi.org/10.1002/bmc.1135
Zhang D, Chow DSL, Renbarger JL (2016) Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC–MS/MS assay. Biomed Chromatogr 30:1648–1655. https://doi.org/10.1002/bmc.3736
Živanović L, Ličanski A, Zečević M, Jocić B, Kostić M (2008) Application of experimental design in optimization of solid phase extraction of mycophenolic acid and mycophenolic acid glucuronide from human urine and plasma and SPE-RP-HPLC method validation. J Pharm Biomed Anal 47:575–585. https://doi.org/10.1016/j.jpba.2008.01.046
Živanović L, Protić A, Zečević M, Jocić B, Kostić M (2009) Multicriteria optimization methodology in development of HPLC separation of mycophenolic acid and mycophenolic acid glucuronide in human urine and plasma. J Pharm Biomed Anal 50:640–648. https://doi.org/10.1016/j.jpba.2008.09.052
Acknowledgements
The authors would like to thank Vice Chancellor for Research of Tabriz University of Medical Sciences for the financial support (63147) of the project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors claim that there is no conflict of interest.
Statement of human and animal rights
All sample donors signed a written consent form confirmed by the Ethics Committee of Tabriz University of Medical Sciences (Ethical code: IR.TBZMED.REC.1396.558).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Niknafs, M., Kaviani, R., Gharekhani, A. et al. Salting-out liquid–liquid microextraction to the determination of mycophenolic acid in plasma samples. Chem. Pap. 74, 1663–1668 (2020). https://doi.org/10.1007/s11696-019-01018-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-019-01018-y